These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29132062)

  • 21. Variation in Nordic Work-Related Cancer Risks after Adjustment for Alcohol and Tobacco.
    Kjaerheim K; Haldorsen T; Lynge E; Martinsen JI; Pukkala E; Weiderpass E; Grimsrud TK
    Int J Environ Res Public Health; 2018 Dec; 15(12):. PubMed ID: 30563223
    [No Abstract]   [Full Text] [Related]  

  • 22. Occupational risk factors for breast cancer among women in Shanghai.
    Petralia SA; Chow WH; McLaughlin J; Jin F; Gao YT; Dosemeci M
    Am J Ind Med; 1998 Nov; 34(5):477-83. PubMed ID: 9787852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer incidence among waiters: 45 years of follow-up in five Nordic countries.
    Reijula J; Kjaerheim K; Lynge E; Martinsen JI; Reijula K; Sparén P; Tryggvadottir L; Weiderpass E; Pukkala E
    Scand J Public Health; 2015 Mar; 43(2):204-11. PubMed ID: 25564114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer incidence among triazine herbicide manufacturing workers.
    MacLennan PA; Delzell E; Sathiakumar N; Myers SL; Cheng H; Grizzle W; Chen VW; Wu XC
    J Occup Environ Med; 2002 Nov; 44(11):1048-58. PubMed ID: 12448356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Smoking-adjusted risk of kidney cancer by occupation: a population-based cohort study of Nordic men.
    Michalek IM; Kinnunen TI; Kjaerheim K; Lynge E; Martinsen JI; Sparen P; Tryggvadottir L; Weiderpass E; Pukkala E
    Acta Oncol; 2020 May; 59(5):582-587. PubMed ID: 32009517
    [No Abstract]   [Full Text] [Related]  

  • 26. Occupational variation in bladder cancer in Nordic males adjusted with approximated smoking prevalence.
    Hadkhale K; Martinsen JI; Weiderpass E; Kjærheim K; Sparén P; Tryggvadóttir L; Lynge E; Pukkala E
    Acta Oncol; 2019 Jan; 58(1):29-37. PubMed ID: 30320536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opportunistic testing versus organized prostate-specific antigen screening: outcome after 18 years in the Göteborg randomized population-based prostate cancer screening trial.
    Arnsrud Godtman R; Holmberg E; Lilja H; Stranne J; Hugosson J
    Eur Urol; 2015 Sep; 68(3):354-60. PubMed ID: 25556937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence and occupational variation of ovarian granulosa cell tumours in Finland, Iceland, Norway and Sweden during 1953-2012: a longitudinal cohort study.
    Bryk S; Pukkala E; Martinsen JI; Unkila-Kallio L; Tryggvadottir L; Sparén P; Kjaerheim K; Weiderpass E; Riska A
    BJOG; 2017 Jan; 124(1):143-149. PubMed ID: 26924812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of prostate-specific antigen testing on familial prostate cancer risk estimates.
    Bratt O; Garmo H; Adolfsson J; Bill-Axelson A; Holmberg L; Lambe M; Stattin P
    J Natl Cancer Inst; 2010 Sep; 102(17):1336-43. PubMed ID: 20724726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer incidence among seafarers and fishermen in the Nordic countries.
    Ugelvig Petersen K; Pukkala E; Martinsen JI; Lynge E; Tryggvadottir L; Weiderpass E; Kjærheim K; Heikkinen S; Hansen J
    Scand J Work Environ Health; 2020 Sep; 46(5):461-468. PubMed ID: 31917456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Occupation and Risk of Kidney Cancer in Nordic Countries.
    Michalek IM; Martinsen JI; Weiderpass E; Kjaerheim K; Lynge E; Sparen P; Tryggvadottir L; Pukkala E
    J Occup Environ Med; 2019 Jan; 61(1):41-46. PubMed ID: 30308621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Occupation, physical activity, and risk of prostate cancer in Shanghai, People's Republic of China.
    Hsing AW; McLaughlin JK; Zheng W; Gao YT; Blot WJ
    Cancer Causes Control; 1994 Mar; 5(2):136-40. PubMed ID: 8167260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostate cancer surveillance by occupation and industry: the Canadian Census Health and Environment Cohort (CanCHEC).
    Sritharan J; MacLeod J; Harris S; Cole DC; Harris A; Tjepkema M; Peters PA; Demers PA
    Cancer Med; 2018 Apr; 7(4):1468-1478. PubMed ID: 29493883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PSA screening, prostate biopsy, and treatment of prostate cancer in the years surrounding the USPSTF recommendation against prostate cancer screening.
    Kearns JT; Holt SK; Wright JL; Lin DW; Lange PH; Gore JL
    Cancer; 2018 Jul; 124(13):2733-2739. PubMed ID: 29781117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usual adult occupation and risk of prostate cancer in West African men: the Ghana Prostate Study.
    Adler C; Friesen MC; Yeboah ED; Tettey Y; Biritwum RB; Adjei AA; Tay E; Okyne V; Mensah JE; Truelove A; Yang B; Kelly SP; Zhou CK; McCullough LE; Pardo L; Hoover RN; Hsing AW; Cook MB; Koutros S
    Occup Environ Med; 2019 Feb; 76(2):71-77. PubMed ID: 30530485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostate-specific antigen (PSA) screening and follow-up investigations in Māori and non-Māori men in New Zealand.
    Obertová Z; Scott N; Brown C; Hodgson F; Stewart A; Holmes M; Lawrenson R
    BMC Fam Pract; 2014 Aug; 15():145. PubMed ID: 25154420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Baseline Prostate-specific Antigen Level in Midlife and Aggressive Prostate Cancer in Black Men.
    Preston MA; Gerke T; Carlsson SV; Signorello L; Sjoberg DD; Markt SC; Kibel AS; Trinh QD; Steinwandel M; Blot W; Vickers AJ; Lilja H; Mucci LA; Wilson KM
    Eur Urol; 2019 Mar; 75(3):399-407. PubMed ID: 30237027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Shift Work and Prostate Cancer Incidence in Industrial Workers: A Historical Cohort Study in a German Chemical Company.
    Hammer GP; Emrich K; Nasterlack M; Blettner M; Yong M
    Dtsch Arztebl Int; 2015 Jul; 112(27-28):463-70. PubMed ID: 26214232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between World Trade Center exposure and excess cancer risk.
    Li J; Cone JE; Kahn AR; Brackbill RM; Farfel MR; Greene CM; Hadler JL; Stayner LT; Stellman SD
    JAMA; 2012 Dec; 308(23):2479-88. PubMed ID: 23288447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for prostate cancer decreases the risk of developing metastatic disease: findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC).
    Schröder FH; Hugosson J; Carlsson S; Tammela T; Määttänen L; Auvinen A; Kwiatkowski M; Recker F; Roobol MJ
    Eur Urol; 2012 Nov; 62(5):745-52. PubMed ID: 22704366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.